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Abstract In this commentary I review the recent paper
by Iyegbe et al. on ‘‘The emerging molecular architecture
of schizophrenia, polygenic risk scores and the clinical
implications for gXe research’’. I discuss how the paper
advances our knowledge of polygenic risk scores for use,
amongst others, in gene-environment interaction studies
and the opportunities and challenges such approaches will
bring to our understanding of the epidemiology of psy-
chotic disorders, including schizophrenia.
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The latest and largest genome-wide association train has
just rolled through Nature, bringing with it the exciting
news that 128 novel and established genetic loci for
schizophrenia have been identified [1]. This news is rightly
being heralded as a potentially major breakthrough in our
understanding of genes important in the risk of schizo-
phrenia, by both reproducing already established risk genes
previously identified in subsamples of the same dataset, as
well as identifying 83 previously unknown loci as potential
aetiological and therapeutic targets [1].
Putting aside staple epidemiological concerns regarding
heterogeneous control sampling of its more than 50 con-
stituent samples, and possible selection biases inherent
therein, the increased power to detect genes with small
effect sizes brings welcome precision to the field of
schizophrenia genetics, as it continues to disentangle the
signal from the noise.
Such discoveries will also be a boon to researchers
investigating the ways in which genetic and environmental
influences combine to affect the risk of experiencing
schizophrenia and other psychotic and genetically related
psychiatric conditions [2]. One possible approach to gene–
environment research is outlined by Iyegbe and colleagues
[3] in their state-of-science review in a recent issue of
Social Psychiatry and Psychiatric Epidemiology, in which
they provide the background, rationale, challenges and
methodological approaches to using polygenic risk scores
in clinical and aetiological practice.
Iyegbe et al. [3] begin their article with a generally well-
balanced and highly accessible overview of the historical
development of the major genetic and environmental dis-
coveries which have been elucidated in schizophrenia
research. They are quick to recognise the redundancy in what
should now be considered a sterile debate over ‘‘genetic’’
versus ‘‘environmental’’ causes. Given a myriad of genetic
and environmental ‘‘loci’’ for schizophrenia dictate low
specificity with regard to both exposure and outcome, it is
natural to assume that mechanisms beyond main effects must
influence the risk of a given psychiatric disorder, or that there
are many mechanisms through which psychosis can occur at
the individual level. Although discussed here in terms of
gene–environment interactions [gXe], other possible mecha-
nisms, including gene expression [4] and gene–environment
correlation [5] require careful, equal consideration; both
genetic and epidemiological expertise will be vital in devel-
oping longitudinal cohort studies capable of investigating
such pathways. Such studies sit at the top of a relatively
intuitive set of observational designs available in epidemio-
logical research, which have various strengths and limitations
depending on the exact research goal or question [6].
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The authors [3] are particularly generous in their
appraisal of findings in relation to ‘‘well-established’’ and
‘‘robust’’ socio-environmental risk factors associated with
schizophrenia risk. Indeed in some cases, epidemiologists
themselves may exercise more caution. For some risk
factors, such as cannabis use [7] or very severe prenatal
malnutrition [8], the evidence base is indeed strong. Else-
where, however, while there is good epidemiological evi-
dence that environmental factors such as migration [9] and
ethnic minority status [10], or urban birth and upbringing
[11, 12], are consistently associated with increased inci-
dence, or risk, the exact social, biological or genetic
exposures which these markers represent, remain unknown.
Further research is required to carefully examine compet-
ing hypotheses, which include the influence of social
stressors [13] such as discrimination [14, 15], inequality
[16] and disadvantage [17], biological stressors [18] such
as infection or malnutrition (including vitamin D) or effect
modification via as yet untested candidate genes. Just as the
large relative risks traditionally associated with a family
history of psychosis may (in part) provide a summary
measure of the totality of genetic (and shared environ-
mental) risk now more accurately partitioned by genome
wide association studies [GWAS], so might the risk asso-
ciated with urban living or minority position be a summary
marker for a range of deleterious environmental or genetic
processes operating further along the causal pathway. For
example, a recent study of 2.4 million people in Sweden
suggests that selection processes (genetic or environmen-
tal) operating at the family level may be responsible for
associations between deleterious environmental factors and
later schizophrenia risk [19].
Indeed, the raison d’etre for any epidemiological study
is not only to elucidate large relative risks but to explain
variation in risk via careful measurement and scrutiny of
other (traditionally, ‘‘confounding’’) variables. Thus, as
psychiatric genetics has traditionally subsumed the envi-
ronment as a noise term in analyses, even the best epide-
miological studies of psychotic disorder may have been
limited in their ability to account for residual or unmea-
sured confounding, from both genetic and environmental
factors, wherein the most valuable aetiological clues may
lie. The ‘‘flaw’’ spotted by Iyegbe et al. [3] in one of our
previous publications on the population impact of such
factors and prevention of schizophrenia [20], thus arises
from a more general limitation of our discipline; the
challenge of conducting epidemiological studies of disor-
ders of very rare incidence, using large representative and
unbiased samples, with comprehensive measurement of all
the social, biological, neurodevelopmental and genetic
factors potentially influencing risk over the life course. As
acknowledged in our original report [20] (pp. 7–8), we
recognised ‘‘that other, unmeasured confounders may be
important, including a family history of psychoses…[I]t is
unlikely that psychosocial risk factors are often sufficient
to cause psychosis, but rather interact with neurodevelop-
mental or genetic vulnerability.’’ Thus, we echo and sup-
port Iyegbe et al.’s [3] view (pp. 175) that there ‘‘is a
relative paucity of datasets able to adequately assess the
effect of joint exposure to genes and environment, which
will be necessary for advancing aetiology and estimating
the true proportion of disease which could be prevented by
the removal of exposure to either or both sets of factors’’.
It follows that risk prediction is a major focus of Iyegbe
and colleagues’ review [3]. They eloquently outline the
basis and method for the development of a polygenic risk
score, drawing on available GWAS data. The polygenic
score represents the within-person sum of all risk alleles for
a given locus of interest multiplied by its (log) odds ratio as
identified in a ‘‘training’’ sample of GWAS data. This
polygenic score is subject to less sampling error as more
data are added from GWAS consortia, but its psychometric
properties currently still fall short of predictive validity
necessary for use in the general population. More inter-
estingly, however, there is increasing evidence that poly-
genic scores may be reaching threshold validity for
predicting those at high risk of psychosis, which potentially
yields exciting opportunities for early intervention research
[21].
Iyegbe et al. [3] should be commended for writing a
highly comprehensive review in clear, understandable
language for epidemiologists and other psychiatric
researchers not working regularly with complex GWAS
data. In doing so their paper raises a number of questions
about the use of polygenic risk scores which could further
aid both research, and the non-familiar researcher. One
useful next stage, for example, would presumably be to
identify the social, clinical, developmental and environ-
mental correlates of high polygenic scores in ultra-high risk
samples and test how these then map on to later transition
to the development of first episode psychosis. Careful
research is needed to determine whether polygenic risk
scores can be augmented with information on family his-
tory of disorder for the practical identification of at-risk
groups, or in order to test putative gXe interactions in
schizophrenia. Researchers will need convincing that a
polygenic risk score for these purposes can enhance
detection of gXe effects over and above those provided by
a family history of psychosis, which may be cheaper, easier
and more practical to implement in large observational or
experimental research designs as a marker for high genetic
risk. Iyegbe et al. [3] discuss the potential role of polygenic
scores in gXe studies, including under Genome Wide
Environment Interaction Studies (GWEIS) approaches.
Space and care are devoted to the complexities and con-
troversies involved in detecting gXe interactions (see also
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[22, 23]), including sample sizes needed to demonstrate
their presence, and more problematically in terms of
power, their absence.
A further challenge to advocates of a polygenic risk
approach in gXe studies is to explain how it can enhance
the understanding of the molecular architecture of schizo-
phrenia, and the pathways through which polygenic risk
might combine with environmental factors to influence the
likelihood of schizophrenia. Since there may be several
different pathways through which various combinations of
genetic and environmental factors act, synergistically or
directly, it is unclear how a single polygenic score would
help clarify those genes or brain systems involved. One
question which arose from Iyegbe et al.’s [3] stimulating
review was the extent to which it would be possible to
identify ‘‘latent’’ polygenic risk scores which sought to
cluster genetic risk according to different theoretical
pathways of disease causation (dopaminergic, glutamater-
gic, GABAergic, calcium channels, etc.). Given theoretical
and empirical evidence to suggest that social environ-
mental stressors may act most strongly on genes involved
in dopamine sensitization [18, 24], such an approach would
presumably increase the a priori theoretical justification
and statistical power to detect putative gXe interactions and
the mechanisms implicated therein. I commend Iyegbe
et al. [3] on a highly readable review of a complex area and
hope that this builds on contemporary gXe endeavours [2]
to lay the rails for future discourse, collaboration and dis-
covery between the social and genetic sciences.
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